2025 Mass Save Climate Leader

About Vertex Pharmaceuticals

Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex was founded in 1989 and has its global headquarters in Boston, Massachusetts.

Why They Are a 2025 Climate Leader

Vertex Pharmaceuticals has been recognized as a 2025 Climate Leader for their ongoing commitment to sustainability and responsible business practices over the last three years. As an example, noteworthy effort, they are slated to occupy Related Beal’s 22 Drydock building in the net zero carbon Innovation Square, which is anticipated to use 98% less natural gas on-onsite and 39% less total energy than a code-minimum building. Some notable measures for Vertex's lab fit-out include: high-performance LED lighting, high performance lab equipment, all-electric commercial kitchen, and demand control ventilation for the office areas. Vertex 's building also features high-performance envelope design, heat pump technologies, and on-site renewable energy generation through rooftop photovoltaics. These energy-efficient technologies will eliminate over 1,320 metric tons of CO2, equivalent to the emissions from driving more than 3.3 million miles in a gas-powered car.